For the Inventor, By the Inventor

Enter assignee name

London, United Kingdom

Imperial Cancer Research Technology, Ltd.

USPTO Granted Patents = 27

CIPO Patents = 4

EPO Patents = 2

Forward Citations = 700

Loading Chart...

Loading Chart...

54 inventors (with patents filed for the assignee):

Andrew P McMahon (5 out of 23 patents)

Philip W Ingham (5 out of 16 patents)

Clifford J Tabin (5 out of 21 patents)

4. Hiroyuki Moritomo (4 out of 28 patents)

5. David Ish-Horowicz (4 out of 8 patents)

6. Julian Hart Lewis (4 out of 8 patents)

7. Spyridon Artavanis-Tsakonas (4 out of 24 patents)

8. Grace E Gray (4 out of 8 patents)

9. Masahiko Hayakawa (4 out of 22 patents)

10. Hiroyuki Kaizawa (4 out of 21 patents)

11. Ken-Ichi Kawaguchi (4 out of 9 patents)

12. Tomonobu Koizumi (4 out of 9 patents)

13. Mayumi Yamano (4 out of 10 patents)

14. Koyo Matsuda (4 out of 13 patents)

15. Minoru Okada (4 out of 31 patents)

27 patents: Sort by Forward Citations

1. 8415303 - Method of treatment using a soluble human delta protein fragment (2013-04-09),

2. 8067586 - Fused heteroaryl derivatives (2011-11-29),

3. 7901686 - Hedgehog antibodies (2011-03-08),

4. 7781215 - Vertebrate embryonic pattern-inducing proteins, and uses related thereto (2010-08-24),

5. 7173029 - Fused heteroaryl derivatives (2007-02-06),

6. 7118890 - Antibodies to vertebrate delta proteins and fragments (2006-10-10),

7. 7060450 - Screening assays for agonists and antagonists of the hedgehog signaling pathway (2006-06-13),

8. 7037915 - Fused heteroaryl derivatives (2006-05-02),

9. 6884775 - Methods and compositions for regulating skeletogenic formation (2005-04-26),

10. 6838457 - Fused heteroaryl derivatives (2005-01-04),

11. 6287854 - Diagnosis of susceptibility to cancer and treatment thereof (2001-09-11),

12. 6268129 - Method of nucleic acid analysis (2001-07-31),

13. 6222020 - Antigens derived from the core protein of the human mammary epithelial mucin (2001-04-24),

14. 6187993 - Transgenic animals as model of psoriasis (2001-02-13),

15. 6165747 - Nucleic acids encoding hedgehog proteins (2000-12-26),

Imperial Cancer Research Technology, Ltd. is a subsidiary of the Institute of Cancer Research, aiming to advance the development of innovative cancer-related technologies. They collaborate with diverse partners worldwide to facilitate the translation of cutting-edge research into clinical applications. With a focus on enhancing the prevention, diagnosis, and treatment of cancer, Imperial Cancer Research Technology plays a crucial role in bridging the gap between scientific discoveries and patient benefits.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

27 Patents

#116 in London

#656 in United Kingdom

#23,290 in the World

London, United Kingdom

Imperial Cancer Research Technology, Ltd.

Forward Citations = 700

54 inventors:

Andrew P McMahon (5 out of 23 patents)

Philip W Ingham (5 out of 16 patents)

Clifford J Tabin (5 out of 21 patents)

4. Hiroyuki Moritomo (4 out of 28 patents)

5. David Ish-Horowicz (4 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…